Journal of cardiac failure
Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up.
Differences Between Ischemic and Nonischemic Cardiomyopathy in Heart Failure Related Cardiogenic Shock.
Epidemiology and Prognostic Significance of Acute Non-Cardiac Organ Dysfunction across Cardiogenic Shock Subtypes: Varshney et al; Non-Cardiac Organ Dysfunction in CS.
Changes in seated pulmonary artery pressure in response to titration of heart failure medications during ambulatory monitoring.
The Role of Lactate Metabolism in Heart Failure and Cardiogenic Shock: Clinical Insights and Therapeutic Implications.
Association between age or duration of diagnosis in obstructive hypertrophic cardiomyopathy and response to mavacamten treatment: Exploratory analysis of the EXPLORER-HCM trial.
CRT Algorithms: Harvesting Low-Hanging Fruit.
Real-World Patient Eligibility for Transcatheter Tricuspid Valve Interventions: Translating Trials to Clinical Practice.
Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.
Genetic interleukin-6 receptor variant is not associated with rejection and mortality after heart transplantation.
